BEIER DAVID W 4
4 · Arcus Biosciences, Inc. · Filed Jun 10, 2019
Insider Transaction Report
Form 4
BEIER DAVID W
Director
Transactions
- Award
Stock Option (right to buy)
2019-06-06+35,000→ 35,000 totalExercise: $7.99Exp: 2029-06-05→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control.